GEODE CAPITAL MANAGEMENT, LLC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 26 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$33,084
+256.1%
368,830
+265.2%
0.00%
Q2 2023$9,291
-65.8%
100,998
-3.5%
0.00%
Q1 2023$27,200
+129423.8%
104,6190.0%0.00%
Q4 2022$21
-99.9%
104,6190.0%0.00%
Q3 2022$26,000
-65.3%
104,6190.0%0.00%
Q2 2022$75,000
-1.3%
104,619
+7.6%
0.00%
Q1 2022$76,000
-21.6%
97,2060.0%0.00%
Q4 2021$97,000
-42.9%
97,2060.0%0.00%
Q3 2021$170,000
-4.0%
97,2060.0%0.00%
Q2 2021$177,000
+17.2%
97,206
+29.4%
0.00%
Q1 2021$151,000
-6.2%
75,1420.0%0.00%
Q4 2020$161,000
-20.3%
75,1420.0%0.00%
Q3 2020$202,000
+32.0%
75,142
+92.8%
0.00%
Q2 2020$153,000
+466.7%
38,979
+8.2%
0.00%
Q1 2020$27,000
-70.0%
36,009
-50.0%
0.00%
Q4 2019$90,000
+275.0%
72,018
+100.0%
0.00%
Q3 2019$24,000
+9.1%
36,0090.0%0.00%
Q2 2019$22,00036,0090.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q1 2022
NameSharesValueWeighting ↓
Allred Capital Management, LLC 52,926$113,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,940$236,0000.01%
PATHSTONE FAMILY OFFICE, LLC 10,050$22,0000.00%
Sowell Financial Services LLC 11,190$24,0000.00%
TWO SIGMA INVESTMENTS, LP 101,949$219,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 32,822$71,0000.00%
UBS Group AG 816$2,0000.00%
IFP Advisors, Inc 50$00.00%
OSAIC HOLDINGS, INC. 6$00.00%
Jacobi Capital Management LLC 1,000$2,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders